BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27306942)

  • 1. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.
    Saeed MJ; Olsen MA; Powderly WG; Presti RM
    J Clin Gastroenterol; 2017 Jan; 51(1):70-76. PubMed ID: 27306942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study.
    Huang YW; Yang SS; Fu SC; Wang TC; Hsu CK; Chen DS; Hu JT; Kao JH
    Hepatology; 2014 Sep; 60(3):807-14. PubMed ID: 24919583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.
    Elkrief L; Chouinard P; Bendersky N; Hajage D; Larroque B; Babany G; Kutala B; Francoz C; Boyer N; Moreau R; Durand F; Marcellin P; Rautou PE; Valla D
    Hepatology; 2014 Sep; 60(3):823-31. PubMed ID: 24841704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.
    Álvaro-Meca A; Jiménez-Sousa MA; Boyer A; Medrano J; Reulen H; Kneib T; Resino S
    BMC Infect Dis; 2016 Mar; 16():122. PubMed ID: 26979964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.
    Li X; Gao Y; Xu H; Hou J; Gao P
    Sci Rep; 2017 Aug; 7(1):9087. PubMed ID: 28831144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.
    Yen YH; Kuo FY; Kee KM; Chang KC; Tsai MC; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
    Dig Liver Dis; 2019 Jan; 51(1):142-148. PubMed ID: 30076015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of unfavorable prognosis of chronic hepatitis C.
    Shchanitcyna SE; Burnevich EZ; Nikulkina EN; Filatova AL; Мoiseev SV; Мukhin NA
    Ter Arkh; 2019 Mar; 91(2):59-66. PubMed ID: 31094173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C.
    Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():327-34. PubMed ID: 27051280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study.
    Huang YW; Wang TC; Lin SC; Chang HY; Chen DS; Hu JT; Yang SS; Kao JH
    Clin Infect Dis; 2013 Dec; 57(12):1695-702. PubMed ID: 24051864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.
    Younossi ZM; Stepanova M; Charlton M; Curry MP; O'Leary JG; Brown RS; Hunt S
    Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):122-132. PubMed ID: 28404069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
    El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
    Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.
    Gordon SC; Pockros PJ; Terrault NA; Hoop RS; Buikema A; Nerenz D; Hamzeh FM
    Hepatology; 2012 Nov; 56(5):1651-60. PubMed ID: 22610658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.
    Maan R; van Tilborg M; Deterding K; Ramji A; van der Meer AJ; Wong F; Fung S; Sherman M; Manns MP; Cornberg M; Hansen BE; Wedemeyer H; Janssen HL; de Knegt RJ; Feld JJ
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1821-1830.e6. PubMed ID: 27404965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.
    Gordon SC; Lamerato LE; Rupp LB; Holmberg SD; Moorman AC; Spradling PR; Teshale E; Xu F; Boscarino JA; Vijayadeva V; Schmidt MA; Oja-Tebbe N; Lu M
    Am J Gastroenterol; 2015 Aug; 110(8):1169-77; quiz 1178. PubMed ID: 26215529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
    Kim GA; Han S; Kim HD; An J; Lim YS
    J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of 1169 hepatitis C chronically infected patients with decompensated cirrhosis in the predirect-acting antiviral era.
    McDonald SA; Innes HA; Aspinall E; Hayes PC; Alavi M; Valerio H; Goldberg DJ; Hutchinson SJ
    J Viral Hepat; 2017 Apr; 24(4):295-303. PubMed ID: 27885753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of chronic hepatitis C patients treated with interferon-alpha: risk of cirrhosis and hepatocellular carcinoma in a single center over 10 years.
    Lee HJ; Yeon JE; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Kim JH; Seo YS; Yim HJ; Byun KS
    Intervirology; 2015; 58(1):14-21. PubMed ID: 25592614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
    Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
    Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.